【结 构 式】 |
【分子编号】23565 【品名】4-bromopyridine 【CA登记号】1120-87-2 |
【 分 子 式 】C5H4BrN 【 分 子 量 】157.9975 【元素组成】C 38.01% H 2.55% Br 50.57% N 8.87% |
合成路线1
该中间体在本合成路线中的序号:(II)The condensation of octylamine (I) with 4-bromopyridine by heating at 180 C gives (4-octylamino)piridine (III), which is then allowed to react with 1,10-dichlorodecane by heating 120-80 C.
【1】 Bailey, D.M.; et al.; Bispyridinamines: A new class of topical antimicrobial agents as inhibitors of dental plaque. J Med Chem 1984, 27, 11, 1457. |
【2】 Castaner, J.; Pento, J.T.; Octenidine hydrochloride. Drugs Fut 1986, 11, 4, 269. |
合成路线2
该中间体在本合成路线中的序号:(II)By condensation of 6-(4aminophenyl)2,3,4,5-tetrahydropyridazin-3-one (I) with 4-bromopyridine (II) in hot DMF, followed by extraction of the free base with Na2CO3 and treatment with ethanolic HCl.
【1】 Kobayashi, M.; Narimatsu, A.; Furuya, R.; Shimooda, I.; Kitada, Y.; Okushima, H. (Mitsubishi Chemical Corp.); 6-(p-Heterocyclylaminophenyl)pyridazin-3-one derivs.. EP 0145019; JP 1985126282; JP 1985197672; US 4661484; US 4971968 . |
【2】 Castaner, R.M.; Serradell, M.N.; Castaner, J.; MCI-154. Drugs Fut 1987, 12, 9, 856. |
合成路线3
该中间体在本合成路线中的序号:(XI)This compound can be prepared by several different ways: 1) The reaction ot 4-(chloromethyl)pyridine (I) with NaCN in toluene - water gives 4-(cyanomethyl)pyridine (II), which is condensed with methyl acrylate (III) yielding dimethyl 4-cyano 4-(4-pyridyl)pimelate (IV). The hydrolysis and decarboxylation of (IV) atfords 4-(4-pyridyl)pimelic acid (V), which is cyclized by means of potassium tert-butoxide giving 4-(4-pyridyl)cyclohexanone (VI). The acetylation of (VI) with acetic anhydride or acetylimidazole affords 2-acetyl(4-4 pyridyl)cyclohexanone (VII), which is finally cyclized with acetylacetamide (VIII) by means of dimethylamine. 2) The cyclization of (VII) with cyanoacetamide (IX) by means of piperidine gives 4-cyano-1-methyl-7-(4-pyridyl)-5,6,7,8-tetrahydro-3(2H)-isoquinolinone (X), which is finally treated with methyl magnesium iodide in ether. 3) The condensation of 4 bromopyridine (XI) and cyclohexanedione monoethyleneketal (XII) by means of butyllithium in THF gives 4-hydroxy-4-(4-pyridyil)cyclohexanone ethyleneketal (XIII), which is dehydrated by treatment with SOCl2 and then with NaOH to afford 4-(4-pyridyl)-3-cyclohexenone ethyleneketal (XIV). Finally, this compound is hydrolyzed with HCl and reduced with H2 over Pd/C in 0.5 N HCl yielding cyclohexanone (VII), already obtained.
【1】 Hirayama, M.; Ito, T.; Kitano, T.; Maruyama, M.; Otsuka, K.; Sannohe, K. (Mitsui Chemicals, Inc.); Isoquinoline derivs.. EP 0207500; US 4639521 . |
【2】 Fukazawa, N.; Kaiho, T.; Yamashita, H. (Mitsui Chemicals, Inc.); Process for preparing 4-acetyl isoquinolinone cpds. JP 1987187467; US 4814458 . |
【3】 Prous, J.; Castaner, J.; MS-857. Drugs Fut 1988, 13, 9, 831. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
10158 | Piperidine | 110-89-4 | C5H11N | 详情 | 详情 | |
(I) | 10844 | 4-(Chloromethyl)pyridine | 10445-91-7 | C6H6ClN | 详情 | 详情 |
(II) | 23556 | 2-(4-pyridinyl)acetonitrile | C7H6N2 | 详情 | 详情 | |
(III) | 14156 | methyl acrylate | 96-33-3 | C4H6O2 | 详情 | 详情 |
(IV) | 23558 | dimethyl 4-cyano-4-(4-pyridinyl)heptanedioate | C15H18N2O4 | 详情 | 详情 | |
(V) | 23559 | 4-(4-pyridinyl)heptanedioic acid | C12H15NO4 | 详情 | 详情 | |
(VI) | 23560 | 4-(4-pyridinyl)cyclohexanone | C11H13NO | 详情 | 详情 | |
(VII) | 23561 | 2-acetyl-4-(4-pyridinyl)cyclohexanone | C13H15NO2 | 详情 | 详情 | |
(VIII) | 23562 | 3-oxobutanamide | 5977-14-0 | C4H7NO2 | 详情 | 详情 |
(IX) | 12122 | Cyanoacetamide; 2-Cyanoacetamide | 107-91-5 | C3H4N2O | 详情 | 详情 |
(X) | 23564 | 1-methyl-3-oxo-7-(4-pyridinyl)-2,3,5,6,7,8-hexahydro-4-isoquinolinecarbonitrile | C16H15N3O | 详情 | 详情 | |
(XI) | 23565 | 4-bromopyridine | 1120-87-2 | C5H4BrN | 详情 | 详情 |
(XII) | 11377 | 1,4-Dioxaspiro[4.5]decan-8-one | 4746-97-8 | C8H12O3 | 详情 | 详情 |
(XIII) | 23567 | 8-(4-pyridinyl)-1,4-dioxaspiro[4.5]decan-8-ol | C13H17NO3 | 详情 | 详情 | |
(XIV) | 23568 | 4-(1,4-dioxaspiro[4.5]dec-7-en-8-yl)pyridine | C13H15NO2 | 详情 | 详情 |
合成路线4
该中间体在本合成路线中的序号:(IV)The asymmetric 1,3-dipolar cycloaddition of the nitrile oxide resulting from 4-bromo-N-hydroxybenzenecarboximidoyl chloride (I) to allyl alcohol (II) in the presence of (R,R)-diisopropyl tartrate and diethylzinc afforded the (R)-5-(hydroxymethyl)isoxazoline (III). Treatment of 4-bromopyridine (IV) with hexamethylditin and dichlorobis(triphenylphosphine)palladium yielded 4-trimethylstannylpyridine (V). Subsequent coupling of bromophenylisoxazoline (III) with stannylpyridine (V) in the presence of tris(dibenzylideneacetone)-dipalladium and tri(2-furyl)phosphine gave rise to the pyridylphenylisoxazole (VI). After conversion of (VI) to the mesylate (VII), treatment with ammonium hydroxide in a sealed vessel provided primary amine (VIII). Finally, acetylation of (VIII) with Ac2O and pyridine furnished the title amide.
【1】 Ukaji, Y.; et al.; Enantioselective synthesis of 2-isoxazolines via asymmetric 1,3-dipolar cycloaddition of nitrile oxides to achiral allyl alcohols. Chem Lett 1993, 11, 1847. |
【2】 Barbachyn, M.R.; Thomas, R.C.; Cleek, G.J. (Pharmacia & Upjohn AB); Isoxazoline derivs. useful as antimicrobials. EP 0920421; US 5990136; WO 9807708 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 32966 | 4-bromo-N-hydroxybenzenecarboximidoyl chloride | C7H5BrClNO | 详情 | 详情 | |
(II) | 12234 | 2-Propen-1-ol; Allyl alcohol | 107-18-6 | C3H6O | 详情 | 详情 |
(III) | 32967 | [(5R)-3-(4-bromophenyl)-4,5-dihydro-5-isoxazolyl]methanol | C10H10BrNO2 | 详情 | 详情 | |
(IV) | 23565 | 4-bromopyridine | 1120-87-2 | C5H4BrN | 详情 | 详情 |
(V) | 32976 | 4-(trimethylstannyl)pyridine | C8H13NSn | 详情 | 详情 | |
(VI) | 32977 | [(5R)-3-[4-(4-pyridinyl)phenyl]-4,5-dihydro-5-isoxazolyl]methanol | C15H14N2O2 | 详情 | 详情 | |
(VII) | 32978 | [(5R)-3-[4-(4-pyridinyl)phenyl]-4,5-dihydro-5-isoxazolyl]methyl methanesulfonate | C16H16N2O4S | 详情 | 详情 | |
(VIII) | 32979 | [(5R)-3-[4-(4-pyridinyl)phenyl]-4,5-dihydro-5-isoxazolyl]methanamine; [(5R)-3-[4-(4-pyridinyl)phenyl]-4,5-dihydro-5-isoxazolyl]methylamine | C15H15N3O | 详情 | 详情 |
合成路线5
该中间体在本合成路线中的序号:(III)The N-Boc protected azaspirocarboxylic acid (I) was simultaneously deprotected and esterified with ethanolic HCl to produce ester (II). Palladium-catalyzed coupling of azaspirocycle (II) with 4-bromopyridine (III) afforded the pyridyl-azaspirocarboxylic acid (IV). This was then condensed with the known amino ester (V) using EDC and HOBt to yield amide (VI). Finally, acid hydrolysis of the ethyl ester group of (VI) furnished the title compound.
【1】 Smyth, M.; Pandey, A.; Mehrota, M.; Scarborough, R.M. (COR Therapeutics, Inc.); Pyridyl-containing spirocyclic cpds. as inhibitors of fibrinogen-dependent platelet aggregation. WO 0130780 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 46838 | 3-(tert-butoxycarbonyl)-3-azaspiro[5.5]undecane-9-carboxylic acid | C16H27NO4 | 详情 | 详情 | |
(II) | 46839 | ethyl 3-azaspiro[5.5]undecane-9-carboxylate | C13H23NO2 | 详情 | 详情 | |
(III) | 23565 | 4-bromopyridine | 1120-87-2 | C5H4BrN | 详情 | 详情 |
(IV) | 46840 | 3-(4-pyridinyl)-3-azaspiro[5.5]undecane-9-carboxylic acid | C16H22N2O2 | 详情 | 详情 | |
(V) | 46841 | ethyl (2S)-3-amino-2-[[(3,5-dimethyl-4-isoxazolyl)sulfonyl]amino]propanoate | C10H17N3O5S | 详情 | 详情 | |
(VI) | 46842 | ethyl (2S)-2-[[(3,5-dimethyl-4-isoxazolyl)sulfonyl]amino]-3-([[3-(4-pyridinyl)-3-azaspiro[5.5]undec-9-yl]carbonyl]amino)propanoate | C26H37N5O6S | 详情 | 详情 |